This report contains market size and forecasts of Depression Medicine in Global, including the following market information:
Global Depression Medicine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Depression Medicine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Tricyclic Antidepressants Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Depression Medicine include Pfizer, AstraZeneca, Eli Lilly and Company, Novartis, GlaxoSmithKline, Otsuka Pharmaceutical, Abbott Laboratories, Gedeon Richter and Janssen Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Depression Medicine companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Depression Medicine Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Depression Medicine Market Segment Percentages, by Type, 2021 (%)
Tricyclic Antidepressants
Serotonin-norepinephrine Inhibitors
Atypical Antipsychotics
Selective Serotonin Reuptake Inhibitors
Benzodiazepines
Tetracyclic Antidepressants
Monoamine Oxidase Inhibitors
Others
Global Depression Medicine Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Depression Medicine Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Depression Medicine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Depression Medicine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Depression Medicine revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Depression Medicine revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
AstraZeneca
Eli Lilly and Company
Novartis
GlaxoSmithKline
Otsuka Pharmaceutical
Abbott Laboratories
Gedeon Richter
Janssen Pharmaceuticals
Lupin Pharmaceuticals
Luye Pharma
MSI Methylation Sciences
Naurex
SK Biopharmaceuticals